ReviewPharmacogenomics and personalized medicine2015

Personalized treatment options for ALK-positive metastatic non-small-cell lung cancer: potential role for Ceritinib.

Hazem El-Osta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.